Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Credicorp | BAP | Oct 10, 2024 | 185.18 | +1.04 |
Credit Acceptance | CACC | Oct 10, 2024 | 454.83 | +0.75 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Oct 10, 2024 | 27.40 | -0.25 |
Credit Suisse Ag | GLDI | Oct 10, 2024 | 156.23 | +0.21 |
Credit Suisse Ag | SLVO | Oct 10, 2024 | 80.97 | +1.14 |
Credit Suisse Asset Management Income Fund | CIK | Oct 10, 2024 | 3.08 | -0.16 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Oct 10, 2024 | 68.02 | +1.25 |
Credit Suisse High Yield Bond Fund | DHY | Oct 10, 2024 | 2.21 | -0.45 |
Credo Technology | CRDO | Oct 10, 2024 | 37.24 | +5.89 |
Crescent Capital BDC | CCAP | Oct 10, 2024 | 18.33 | +0.44 |
Crescent Energy | CRGY | Oct 10, 2024 | 13.21 | +0.53 |
Cresud A ADR | CRESY | Oct 10, 2024 | 9.56 | +2.47 |
Crexendo | CXDO | Oct 10, 2024 | 4.98 | -1.39 |
CRH | CRH | Oct 10, 2024 | 90.50 | +0.50 |
Cricut A | CRCT | Oct 10, 2024 | 6.35 | -0.94 |
Crinetics Pharmaceuticals | CRNX | Oct 10, 2024 | 51.78 | +2.13 |
CRISPR Therapeutics | CRSP | Oct 10, 2024 | 45.39 | -0.02 |
Criteo ADR | CRTO | Oct 10, 2024 | 40.28 | -0.81 |
Critical Metals | CRML | Oct 10, 2024 | 6.70 | -1.62 |
Crocs | CROX | Oct 10, 2024 | 136.74 | +1.21 |
Cronos Group | CRON | Oct 10, 2024 | 2.11 | -0.47 |
Cross Country Healthcare | CCRN | Oct 10, 2024 | 12.18 | -0.57 |
Cross Timbers Royalty Royalty Trust | CRT | Oct 10, 2024 | 10.43 | +0.43 |
CrossAmerica Partners LP Unit | CAPL | Oct 10, 2024 | 21.85 | +2.34 |
CrossFirst Bankshares | CFB | Oct 10, 2024 | 15.79 | +0.25 |
CrowdStrike A | CRWD | Oct 10, 2024 | 314.92 | +5.56 |
Crown Castle | CCI | Oct 10, 2024 | 109.94 | -1.93 |
Crown Crafts | CRWS | Oct 10, 2024 | 4.83 | -0.20 |
Crown ElectroKinetics | CRKN | Oct 10, 2024 | 1.28 | +9.40 |
Crown Holdings | CCK | Oct 10, 2024 | 91.60 | -1.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.